Medication info

Brandron Tablet 150mg (Ibandronate Sodium Monohydrate)

Prescription medicationTabletOralExpired
Ingredient · strength
Ibandronate Sodium Monohydrate›168.75mg / 1 tablet
Manufacturer / importer
Jinyang Pharmaceutical Co., Ltd.
Appearance
White to nearly white rectangular film-coated tablet
Packaging
1 tablet (1 tablet/PTPx1)
Approval status
Expired

MFDS item code 201310210 · Approved 2013.11.20

This product's status changed to Expired on 2023.11.20. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of osteoporosis in postmenopausal women
Who takes it
Adults · Children
Adult dose
Take 1 tablet once monthly, regularly, on the same day each month in the morning, with a sufficient amount of water, at least 1 hour before consuming food, beverages (other than water), or other oral medications or dietary supplements (including calcium): - This medicine should be swallowed with a sufficient amount of water (180-240ml) while standing or sitting upright, and you should not lie down for 60 minutes after taking it. - Since mineral water may reduce the absorption of this medicine, take it with plain water. - To avoid esophageal ulcers, do not chew or suck the tablet. If a patient forgets to take the medicine on the scheduled monthly dosing day - If 8 days or more remain until the next scheduled dosing day, take 1 tablet the morning after realizing that a dose was missed, and thereafter take 1 tablet monthly on the originally scheduled dosing day. - If 7 days or fewer remain until the next scheduled dosing day, take 1 tablet on the next scheduled dosing day, and thereafter continue to take 1 tablet monthly on the originally scheduled dosing day. - Do not take 2 tablets in the same week. Patients with inadequate dietary intake should supplement with calcium or vitamin D. Patients with hepatic impairment No dose adjustment is necessary. Patients with renal impairment No dose adjustment is necessary for patients with mild or moderate renal impairment with a creatinine clearance of 30mL/min or higher. Use of this medicine is not recommended in patients with a creatinine clearance below 30mL/min because clinical experience is insufficient. Elderly patients No dose adjustment is necessary.
Child dose
Efficacy and safety in children 18 years of age or younger have not been studied.

Ingredients

Manufacturer
Jinyang Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of osteoporosis in postmenopausal women

  • Osteoporosis
View approved original text

This medication is used to treat osteoporosis that may occur in postmenopausal women. It helps to increase bone strength and prevent bone density loss, thereby reducing the risk of fractures. Regular use is effective in improving bone health and preventing fractures that interfere with daily life.

How to take

Adult dose

Take 1 tablet once monthly, regularly, on the same day each month in the morning, with a sufficient amount of water, at least 1 hour before consuming food, beverages (other than water), or other oral medications or dietary supplements (including calcium): - This medicine should be swallowed with a sufficient amount of water (180-240ml) while standing or sitting upright, and you should not lie down for 60 minutes after taking it. - Since mineral water may reduce the absorption of this medicine, take it with plain water. - To avoid esophageal ulcers, do not chew or suck the tablet. If a patient forgets to take the medicine on the scheduled monthly dosing day - If 8 days or more remain until the next scheduled dosing day, take 1 tablet the morning after realizing that a dose was missed, and thereafter take 1 tablet monthly on the originally scheduled dosing day. - If 7 days or fewer remain until the next scheduled dosing day, take 1 tablet on the next scheduled dosing day, and thereafter continue to take 1 tablet monthly on the originally scheduled dosing day. - Do not take 2 tablets in the same week. Patients with inadequate dietary intake should supplement with calcium or vitamin D. Patients with hepatic impairment No dose adjustment is necessary. Patients with renal impairment No dose adjustment is necessary for patients with mild or moderate renal impairment with a creatinine clearance of 30mL/min or higher. Use of this medicine is not recommended in patients with a creatinine clearance below 30mL/min because clinical experience is insufficient. Elderly patients No dose adjustment is necessary.

Child dose

Efficacy and safety in children 18 years of age or younger have not been studied.

Precautions

This medicine should not be used in certain patients. For example, it should not be administered to patients with an allergy to this medication or its components, or those with untreated low calcium levels. Additionally, patients who cannot sit or stand upright for at least 60 minutes or those with esophageal issues that make swallowing difficult should not take this medication. It contains lactose; hence, it should not be administered to patients with lactose intolerance or certain genetic metabolic disorders. Care should be taken when administering this medication to patients with severe renal insufficiency. While taking this medication, gastrointestinal disturbances such as dyspepsia, nausea, abdominal pain, diarrhea, headache, muscle pain, joint pain, and rash may occur. Particularly, during the first administration, patients may temporarily experience influenza-like symptoms such as joint pain, muscle pain, fever, chills, and fatigue, which are usually mild and resolve without treatment. This medication may irritate the gastrointestinal mucosa, so if symptoms such as esophagitis or esophageal ulcers, or difficulty swallowing occur, discontinue use immediately and consult a doctor. Furthermore, patients with gastrointestinal disorders should exercise caution when taking this medication. As a bisphosphonate, cases of jaw osteonecrosis or external auditory canal osteonecrosis have been reported rarely, and oral examinations are recommended before dental treatments. It is advisable to avoid excessive dental treatments while taking this medication. Additionally, severe bone, joint, or muscle pain may occur during the course of this medication, and if this happens, patients should consult a doctor. There is also a possibility of atypical fractures occurring in the femur, so any pain in the thigh or groin should be evaluated. This medication may hinder absorption if taken with food, calcium, aluminum, magnesium, iron, etc., so it should be taken with a sufficient amount of water at least one hour prior to consuming food or medications that contain these components. It is safest not to use this medication during pregnancy or breastfeeding. No dosage adjustment is required for older adults, but the safety and effectiveness for children under 18 years have not been established. In cases of overdose, gastrointestinal disturbances or hypocalcemia may appear; do not induce vomiting and maintain an upright position. This medication should be stored out of the reach of children, and unused medication should be disposed of appropriately to prevent environmental contamination.

Side effects

Dyspepsia, nausea, abdominal pain, diarrhea, bloating, gastroesophageal reflux disease, headache, influenza-like illness, fatigue, myalgia, arthralgia, rash, gastritis, esophagitis, muscle cramps, musculoskeletal pain, musculoskeletal stiffness, dysphagia, vomiting, esophageal ulcer, esophageal stricture, dizziness, low back pain, duodenitis, hypersensitivity reaction, angioedema, facial swelling, urticaria, uveitis, scleritis, osteonecrosis of the jaw and external auditory canal, anaphylactic reaction, shock, exacerbation of asthma, Stevens-Johnson syndrome, erythema multiforme, vesicular dermatitis, atypical periprosthetic and intertrochanteric femoral fractures, abnormal sensations in the eyes, weakness, pruritus

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. In addition, it is best to avoid storing the medication in excessively hot or cold places, keeping it at room temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

White to nearly white rectangular film-coated tablet

Package unit

1 tablet (1 tablet/PTPx1)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.